BILL · 2025–26 SESSION

HB 1425: Pharmacogenomic testing

Requiring coverage of pharmacogenomic testing for psychotropic medications.

Summary

Requires health plans, including health plans offered to public employees, and the state's Medicaid program to provide coverage for pharmacogenetic testing for psychotropic medications.

From the House Bill Analysis 2025 (HB 1425), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee

AN ACT Relating to requiring coverage of pharmacogenomic testing for psychotropic medications;

No recorded floor votes. This measure never reached a floor vote.

Bill numbers restart every two years, so the same number is a different bill in each session.

HB 1425 (2023–24) Municipal annexations · Enacted · Chapter 351, Laws of 2023
HB 1425 (2021–22) CTC student scholarships · Enacted · Chapter 133, Laws of 2021
HB 1425 (2019–20) Bilingual instruction prg. · Did not pass · died in committee
HB 1425 (2017–18) Ed. savings account pilot · Did not pass · died in committee
HB 1425 (2015–16) Advisory committees, etc. · Did not pass · died in committee
HB 1425 (2013–14) Housing organizations · Did not pass · died in committee
HB 1425 (2011–12) Health sciences authorities · Enacted · Chapter 155, Laws of 2011
HB 1425 (2009–10) Prohibiting small loans · Did not pass · died in committee